找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunomodulators and Biologics in Dermatologic Treatment; Turning Theory into Neal Bhatia Book 2024 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: Helmet
21#
發(fā)表于 2025-3-25 05:56:40 | 只看該作者
22#
發(fā)表于 2025-3-25 11:12:07 | 只看該作者
JAK Inhibitors as Immunomodulators, transcription of other effector cytokines. The clinical relevance to dermatologists including the impact on inflammation and pathogenesis of diseases such as atopic dermatitis, psoriasis, vitiligo, and other conditions including clinical trial data, topical and systemic therapies, and future medica
23#
發(fā)表于 2025-3-25 12:26:16 | 只看該作者
24#
發(fā)表于 2025-3-25 18:59:28 | 只看該作者
25#
發(fā)表于 2025-3-25 20:26:20 | 只看該作者
Antibiotics and Antimicrobials as Immunomodulators,kill pathogens or to inhibit their reproduction or growth. However, many of these agents have additional immunomodulatory effects, direct and indirect, due to common pathways and structural similarities between pathogens and humans. Dermatologists are amongst the top prescribers of antimicrobial age
26#
發(fā)表于 2025-3-26 01:55:25 | 只看該作者
Integrative Therapies as Immunomodulators,rings together many facets of immunology and immunomodulation. The diverse origins of therapies, including herbal, botanical, spice roots, and other natural sources, give rise to many applications as anti-inflammatory agents. Dermatologists incorporate integrative therapies in diseases such as acne,
27#
發(fā)表于 2025-3-26 04:19:03 | 只看該作者
28#
發(fā)表于 2025-3-26 10:44:11 | 只看該作者
Immunomodulators for Common Dermatologic Disorders: A Focus on Acne, Rosacea, Seborrheic Dermatitis of inflammation in disease progression. Treatment approaches for these conditions involve targeting various contributing factors, with a focus on combination therapies tailored to disease severity. Recent advancements in microencapsulated formulations and novel agents offer promising avenues for en
29#
發(fā)表于 2025-3-26 12:52:21 | 只看該作者
30#
發(fā)表于 2025-3-26 18:07:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 21:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永寿县| 云霄县| 辉南县| 犍为县| 清新县| 荣成市| 康马县| 平度市| 兖州市| 永兴县| 兴化市| 五常市| 靖西县| 衡东县| 连南| 眉山市| 陇西县| 莱阳市| 兰坪| 自治县| 如东县| 阿图什市| 樟树市| 左云县| 南澳县| 泽普县| 弋阳县| 浪卡子县| 福清市| 贞丰县| 巴林左旗| 麻城市| 临沧市| 花莲市| 老河口市| 禄丰县| 吐鲁番市| 东光县| 西丰县| 九江县| 林州市|